Indian Journal of Clinical and Experimental Ophthalmology

Print ISSN: 2395-1443

Online ISSN: 2395-1451

CODEN : IJCEKF

Indian Journal of Clinical and Experimental Ophthalmology (IJCEO) is open access, a peer-reviewed medical journal, published quarterly, online, and in print, by the Innovative Education and Scientific Research Foundation (IESRF) since 2015. To fulfil our aim of rapid dissemination of knowledge, we publish articles ‘Ahead of Print’ on acceptance. In addition, the journal allows free access (Open Access) to its content, which is likely to attract more readers and citations of articles published in IJCEO. Manuscripts must be prepared in more...

Article type

Original Article


Article page

333- 338


Authors Details

Geetika Srivastava, Harsimran Kaur Bhatia, Uma Sridhar


Article Metrics


View Article As

 


Downlaod Files

   






Article statistics

Viewed: 1600

PDF Downloaded: 742


A study to evaluate safety and efficacy of corneal collagen cross-linking with riboflavin in keratoconus patients


Original Article

Author Details : Geetika Srivastava, Harsimran Kaur Bhatia, Uma Sridhar

Volume : 4, Issue : 3, Year : 2018

Article Page : 333-338

https://doi.org/10.18231/2395-1451.2018.0075



Suggest article by email

Get Permission

Abstract

Introduction: Keratoconus is a disorder of progressive corneal steepening, resulting in cone shaped protrusion of cornea, corneal thinning, myopia and astigmatism.
Objectives: To assess the efficacy and safety of corneal collagen cross-linking with Riboflavin in the management of keratoconus.
Materials and Methods: The study was conducted at an eye hospital over a period of 22 months to evaluate utility of corneal collagen cross-linking in treatment of keratoconus. Study group included 10 eyes (6 right and 4 left) of 8 patients (6 males and 2 females) with one year follow-up.
Results: Mean age of study population was 24.25 years (SD=5.97; SE=2.11). The mean logMAR UCVA prior to CXL was 0.85 which improved to 0.57 at 12 months. Mean baseline BCVA was 0.464 logMAR, this improved to 0.170 logMAR at 12 months. At baseline a mean SimK astigmatism was 4.99 (SD= 2.56) and this decrease to 4.72 at 12 months.
Conclusion: Present study showed improved visual acuity (both UCVA and BSCVA), stable topographic parameters, stable visual acuity and stable endothelial cell counts over a period of 12 months follow up, indicating that corneal collagen cross-linking with riboflavin is a safe and effective treatment option for keratoconus.

Keywords: Corneal collagen cross-linking and visual acuity, Keratoconus.


How to cite : Srivastava G, Bhatia H K, Sridhar U, A study to evaluate safety and efficacy of corneal collagen cross-linking with riboflavin in keratoconus patients. Indian J Clin Exp Ophthalmol 2018;4(3):333-338

This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.